Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in Parkinson disease patients with a GBA mutation from Japan and the rest of the world: Results from part 1 of the MOVES-PD study
暂无分享,去创建一个
P. Svenningsson | J. Kulisevsky | C. Waters | T. Simuni | T. Hatano | T. Gasser | H. Saiki | R. Takahashi | S. Isaacson | S. Sardi | P. Minini | Yuji Takahashi | M. Katsuno | L. Guedes | A. Ji | J. Sharma | T. Fischer | S. Saubadu | A. Wills | Sebastiaan J. M. Gaemers | B. Nembo | M. J. Peterschmitt